Arbitration Transparency Act of 2017

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

Client expense: $1,430,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. H.R. 6903 (Safe Cosmetics and Personal Care Products Act of 2018); amends current law to ensure the safety of cosmetics and personal care products. H.R. 919 (Blitz Gas Can bill). General issues pertaining to Asbestos Bankruptcy Trusts. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

H.R. 10 Financial Regulatory Reform H.R. 45 Financial Regulatory Reform H.R. 70 Federal Advisory Committee Act Amendments H.R. 493 Wall Street H.R. 585 Pre-Dispute Arbitration Agreement Prohibition H.R. 832 Consumer Financial Products Dispute Proceedings H.R. 1018 Director of the Bureau of Consumer Financial Protection H.R. 1031 Bureau of Consumer Financial Protection H.R. 1459 Regular Appropriations Process S. 365 Fund Transfer Funding Cap S. 370 Bureau of Consumer Financial Protection S. 387 Consumer Financial Protection Bureau Appropriations H.R. 2553 Bureau of Consumer Financial Protection H.R. 2750 Office of Financial Research Independent Funding S. 923 Financial Institutions Regulations Exemption H.R. 3312 Bank Holding Companies and Enhanced Supervision S. 1579 Consumer Financial Protection Advisory Boards S. 1744 Securities and Exchange Commission Regulations H.R. 4061 Financial Stability Oversight Council H.R. 4293 Comprehensive Capital Analysis and Review Process H.R. 4302 Congressional Accountability for Emergency Lending H.R. 4625 Development & Implementation of Artificial Intelligence H.R. 5266 Financial Product Safety Commission S. 2217 Development & Implementation of Artificial Intelligence H.R. 5470 Office of Financial Research H.R. 5534 Procedures for Guidance S. 2702 Authority of Bureau of Consumer Financial Protection H.R. 6741 Monetary Policy Transparency and Accountability H.R. 2133 CLEARR Act of 2017 S. 3443 Consumer Financial Protection Guidance Procedures

Client expense: $1,070,000 · Firm income: Not reported

H.R. 985 - Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act - SUPPORT H.R. 720 / S. 237 - Lawsuit Abuse Reduction Act (LARA) - SUPPORT H.R. 725 - Innocent Party Protection Act (formally Fraudulent Joinder Prevention Act) - SUPPORT H.R. 1215 - Protecting Access to Care Act - SUPPORT H.R. 1876 - Good Samaritan Health Professionals Act - SUPPORT H.R. 732 / H.R. 522 / S. 333 - Stop Settlement Slush Funds Act - SUPPORT H.R. 1033 / S. 378 - Open Book on Equal Access to Justice Act - SUPPORT H.R. 469 / S. 119 - Congressional Article I Powers Strengthening Act (formally called Sunshine for Regulatory Decrees and Settlements Act) - SUPPORT H.R. 4570 / H.R. 4734 / S. 2203 - Ending Forced Arbitration of Sexual Harassment Act - OPPOSE H.R. 1396 / S. 550 - Restoring Statutory Rights and Interests of the States Act - OPPOSE S. 542 - Safety Over Arbitration Act - OPPOSE H.R. 832 - Arbitration Transparency Act - OPPOSE H.R. 1414 / S. 552 - Justice for Victims of Fraud Act - OPPOSE H.R. 2631 / S. 646 - Justice for Service Members and Veterans Act - OPPOSE S. 647 - Mandatory Arbitration Transparency Act - OPPOSE H.R. 1374 / S. 537 - Arbitration Fairness Act - OPPOSE

Client expense: $10,000 · Firm income: Not reported

Work to establish Federal limits on pre-dispute arbitration agreements. Work in support of amendments to the Federal Arbitration Act, including enactment of S.537 and similar bills that would reduce or eliminate the use of predispute arbitration agreements. Work in opposition to H.R.906, the Further Asbestos Claims Transparency Act of 2017. Work in opposition to H.R.720 and S.237, the Lawsuit Abuse Reduction Act of 2017; H.R.985, the Fairness in Class Action and Furthering Asbestos Claim Transparency Act of 2017; H.R. 725, the Innocent Party Protection Act; H.R. 732/H.R. 522/S. 333, Stop Settlements Slush Funds Act. Work in support of H.R. 1396 / S. 550 Restoring Statutory Rights and Interests of the States Act; H.R. 832, Arbitration Transparency Act; H.R. 1374/S. 537/S. 2591, Arbitration Fairness Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

Issues related to Dodd-Frank; H.R. 45 (provisions related to Regulatory Relief) H.R. 70 (provisions related to Financial Reform) H.R. 493 (provisions related to Dodd-Frank Reform) H.R. 585 (provisions related to Financial Reform) H.R. 832 (provisions related to Consumer Financial Products) H.R. 1018 (provisions related to CFPB) H.R. 1031 (provisions related to CFPB) H.R. 1459 (provisions related to FSOC) H.R. 1637 (provisions related to CFPB) S. 365 (provisions related to Dodd-Frank Reform) S. 387 (provisions related to CFPB) H.R. 4061 (provisions related to Dodd-Frank FSOC) H.R. 3762 (provisions related to Dodd-Frank FIO) H.R. 3861 (provisions related to Dodd-Frank FIO) H.R. 3746 (provisions related to Dodd-Frank CFPB) H.R. 4537 (provisions related to Dodd-Frank FIO) S. 1360 (provisions related to International Insurance) S. 2155, Sec. 211 (provisions related to International Capital Standards)

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 10 Financial Regulatory Reform H.R. 45 Financial Regulatory Reform H.R. 70 Federal Advisory Committee Act Amendments H.R. 493 Wall Street H.R. 585 Pre-Dispute Arbitration Agreement Prohibition H.R. 832 Consumer Financial Products Dispute Proceedings H.R. 1018 Director of the Bureau of Consumer Financial Protection H.R. 1031 Bureau of Consumer Financial Protection H.R. 1459 Regular Appropriations Process S. 365 Fund Transfer Funding Cap S. 370 Bureau of Consumer Financial Protection S. 387 Consumer Financial Protection Bureau Appropriations H.R. 2553 Bureau of Consumer Financial Protection H.R. 2750 Office of Financial Research Independent Funding S. 923 Financial Institutions Regulations Exemption H.R. 3312 Bank Holding Companies and Enhanced Supervision S. 1579 Consumer Financial Protection Advisory Boards S. 1744 Securities and Exchange Commission Regulations H.R. 4061 Financial Stability Oversight Council H.R. 4293 Comprehensive Capital Analysis and Review Process H.R. 4302 Congressional Accountability for Emergency Lending H.R. 4625 Development & Implementation of Artificial Intelligence H.R. 5266 Financial Product Safety Commission S. 2217 Development & Implementation of Artificial Intelligence H.R. 5470 Office of Financial Research H.R. 5534 Procedures for Guidance S. 2702 Authority of Bureau of Consumer Financial Protection

Client expense: $1,590,000 · Firm income: Not reported

Work to establish Federal limits on pre-dispute arbitration agreements. Work in support of amendments to the Federal Arbitration Act, including enactment of S.537 and similar bills that would reduce or eliminate the use of predispute arbitration agreements. Work in opposition to H.R.906, the Further Asbestos Claims Transparency Act of 2017. Work in opposition to H.R.720 and S.237, the Lawsuit Abuse Reduction Act of 2017; H.R.985, the Fairness in Class Action and Furthering Asbestos Claim Transparency Act of 2017; H.R. 725, the Innocent Party Protection Act; H.R. 732/H.R. 522/S. 333, Stop Settlements Slush Funds Act. Work in support of H.R. 1396 / S. 550 Restoring Statutory Rights and Interests of the States Act; H.R. 832, Arbitration Transparency Act; H.R. 1374/S. 537/S. 2591, Arbitration Fairness Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 985 - Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act - SUPPORT H.R. 720 / S. 237 - Lawsuit Abuse Reduction Act (LARA) - SUPPORT H.R. 725 - Innocent Party Protection Act (formally Fraudulent Joinder Prevention Act) - SUPPORT H.R. 1215 - Protecting Access to Care Act - SUPPORT H.R. 1876 - Good Samaritan Health Professionals Act - SUPPORT H.R. 732 / H.R. 522 / S. 333 - Stop Settlement Slush Funds Act - SUPPORT H.R. 1033 / S. 378 - Open Book on Equal Access to Justice Act - SUPPORT H.R. 469 / S. 119 - Congressional Article I Powers Strengthening Act (formally called Sunshine for Regulatory Decrees and Settlements Act) - SUPPORT H.R. 4570 / H.R. 4734 / S. 2203 - Ending Forced Arbitration of Sexual Harassment Act - OPPOSE H.R. 1396 / S. 550 - Restoring Statutory Rights and Interests of the States Act - OPPOSE S. 542 - Safety Over Arbitration Act - OPPOSE H.R. 832 - Arbitration Transparency Act - OPPOSE H.R. 1414 / S. 552 - Justice for Victims of Fraud Act - OPPOSE H.R. 2631 / S. 646 - Justice for Service Members and Veterans Act - OPPOSE S. 647 - Mandatory Arbitration Transparency Act - OPPOSE H.R. 1374 / S. 537 - Arbitration Fairness Act - OPPOSE

Client expense: $10,000 · Firm income: Not reported

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

Work to establish Federal limits on pre-dispute arbitration agreements. Work in support of amendments to the Federal Arbitration Act, including enactment of S.537 and similar bills that would reduce or eliminate the use of predispute arbitration agreements. Work in opposition to H.R.906, the Further Asbestos Claims Transparency Act of 2017. Work in opposition to H.R.720 and S.237, the Lawsuit Abuse Reduction Act of 2017; H.R.985, the Fairness in Class Action and Furthering Asbestos Claim Transparency Act of 2017; H.R. 725, the Innocent Party Protection Act; H.R. 732/H.R. 522/S. 333, Stop Settlements Slush Funds Act. Work in support of H.R. 1396 / S. 550 Restoring Statutory Rights and Interests of the States Act; H.R. 832, Arbitration Transparency Act; H.R. 1374/S. 537/S. 2591, Arbitration Fairness Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

Issues related to Dodd-Frank; H.R. 45 re Regulatory Relief H.R. 70 re Financial Reform H.R. 493 re Dodd-Frank Reform H.R. 585 re Financial Reform H.R. 832 re Consumer Financial Products H.R. 1018 re CFPB H.R. 1031 re CFPB H.R. 1459 re FSOC H.R. 1637 re CFPB S. 365 re CFPB S. 370 re Dodd-Frank Reform S. 387 re CFPB H.R. 4061 re Dodd-Frank FSOC H.R. 3762 re Dodd-Frank FIO H.R. 3861 re Dodd-Frank FIO H.R. 3746 re Dodd-Frank CFPB H.R. 4537 re Dodd-Frank FIO

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 10 Financial Regulatory Reform H.R. 45 Financial Regulatory Reform H.R. 70 Federal Advisory Committee Act Amendments H.R. 493 Wall Street H.R. 585 Pre-Dispute Arbitration Agreement Prohibition H.R. 832 Consumer Financial Products Dispute Proceedings H.R. 1018 Director of the Bureau of Consumer Financial Protection H.R. 1031 Bureau of Consumer Financial Protection H.R. 1459 Regular Appropriations Process S. 365 Fund Transfer Funding Cap S. 370 Bureau of Consumer Financial Protection S. 387 Consumer Financial Protection Bureau Appropriations H.R. 2553 Bureau of Consumer Financial Protection H.R. 2750 Office of Financial Research Independent Funding S. 923 Financial Institutions Regulations Exemption H.R. 3312 Bank Holding Companies and Enhanced Supervision S. 1579 Consumer Financial Protection Advisory Boards S. 1744 Securities and Exchange Commission Regulations H.R. 4061 Financial Stability Oversight Council H.R. 4293 Comprehensive Capital Analysis and Review Process H.R. 4302 Congressional Accountability for Emergency Lending H.R. 4625 Development & Implementation of Artificial Intelligence H.R. 5266 Financial Product Safety Commission S. 2217 Development & Implementation of Artifical Intelligence

Client expense: $1,220,000 · Firm income: Not reported

H.R. 985 - Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act - SUPPORT H.R. 720 / S. 237 - Lawsuit Abuse Reduction Act (LARA) - SUPPORT H.R. 725 - Innocent Party Protection Act (formally Fraudulent Joinder Prevention Act) - SUPPORT H.R. 1215 - Protecting Access to Care Act - SUPPORT H.R. 1876 - Good Samaritan Health Professionals Act - SUPPORT H.R. 732 / H.R. 522 / S. 333 - Stop Settlement Slush Funds Act - SUPPORT H.R. 1033 / S. 378 - Open Book on Equal Access to Justice Act - SUPPORT H.R. 469 / S. 119 - Congressional Article I Powers Strengthening Act (formally called Sunshine for Regulatory Decrees and Settlements Act) - SUPPORT H.R. 4570 / H.R. 4734 / S. 2203 - Ending Forced Arbitration of Sexual Harassment Act - OPPOSE H.R. 1396 / S. 550 - Restoring Statutory Rights and Interests of the States Act - OPPOSE S. 542 - Safety Over Arbitration Act - OPPOSE H.R. 832 - Arbitration Transparency Act - OPPOSE H.R. 1414 / S. 552 - Justice for Victims of Fraud Act - OPPOSE H.R. 2631 / S. 646 - Justice for Service Members and Veterans Act - OPPOSE S. 647 - Mandatory Arbitration Transparency Act - OPPOSE H.R. 1374 / S. 537 - Arbitration Fairness Act - OPPOSE

Client expense: $10,000 · Firm income: Not reported

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues.

Issues related to Dodd-Frank; H.R. 45 re Regulatory Relief H.R. 70 re Financial Reform H.R. 493 re Dodd-Frank Reform H.R. 585 re Financial Reform H.R. 832 re Consumer Financial Products H.R. 1018 re CFPB H.R. 1031 re CFPB H.R. 1459 re FSOC H.R. 1637 re CFPB S. 365 re CFPB S. 370 re Dodd-Frank Reform S. 387 re CFPB H.R. 4061 re Dodd-Frank FSOC H.R. 3762 re Dodd-Frank FIO H.R. 3861 re Dodd-Frank FIO H.R. 3746 re Dodd-Frank CFPB H.R. 4537 re Dodd-Frank FIO

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 10 Financial Regulatory Reform H.R. 45 Financial Regulatory Reform H.R. 70 Federal Advisory Committee Act Amendments H.R. 493 Wall Street H.R. 585 Pre-Dispute Arbitration Agreement Prohibition H.R. 832 Consumer Financial Products Dispute Proceedings H.R. 1018 Director of the Bureau of Consumer Financial Protection H.R. 1031 Bureau of Consumer Financial Protection H.R. 1459 Regular Appropriations Process S. 365 Fund Transfer Funding Cap S. 370 Bureau of Consumer Financial Protection S. 387 Consumer Financial Protection Bureau Appropriations H.R. 2553 Bureau of Consumer Financial Protection H.R. 2750 Office of Financial Research Independent Funding S. 923 Financial Institutions Regulations Exemption H.R. 3312 Bank Holding Companies and Enhanced Supervision S. 1579 Consumer Financial Protection Advisory Boards S. 1744 Securities and Exchange Commission Regulations H.R. 4061 Financial Stability Oversight Council H.R. 4293 Comprehensive Capital Analysis and Review Process H.R. 4302 Congressional Accountability for Emergency Lending

Client expense: $1,390,000 · Firm income: Not reported

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues.

Issues related to Dodd-Frank; H.R. 45 re Regulatory Relief H.R. 70 re Financial Reform H.R. 493 re Dodd-Frank Reform H.R. 585 re Financial Reform H.R. 832 re Consumer Financial Products H.R. 1018 re CFPB H.R. 1031 re CFPB H.R. 1459 re FSOC H.R. 1637 re CFPB S. 365 re CFPB S. 370 re Dodd-Frank Reform S. 387 re CFPB H.R. 4061 re Dodd-Frank FSOC H.R. 3762 re Dodd-Frank FIO H.R. 3861 re Dodd-Frank FIO H.R. 3746 re Dodd-Frank FPB

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 10 Financial Regulatory Reform H.R. 45 Financial Regulatory Reform H.R. 70 Federal Advisory Committee Act Amendments H.R. 493 Wall Street H.R. 585 Pre-Dispute Arbitration Agreement Prohibition H.R. 832 Consumer Financial Products Dispute Proceedings H.R. 1018 Director of the Bureau of Consumer Financial Protection H.R. 1031 Bureau of Consumer Financial Protection H.R. 1459 Regular Appropriations Process S. 365 Fund Transfer Funding Cap S. 370 Bureau of Consumer Financial Protection S. 387 Consumer Financial Protection Bureau Appropriations H.R. 2553 Bureau of Consumer Financial Protection H.R. 2750 Office of Financial Research Independent Funding S. 923 Financial Institutions Regulations Exemption H.R. 3312 Bank Holding Companies and Enhanced Supervision S. 1579 Consumer Financial Protection Advisory Boards S. 1744 Securities and Exchange Commission Regulations

Client expense: $1,250,000 · Firm income: Not reported

H.R. 10 Financial Regulatory Reform H.R. 45 Financial Regulatory Reform H.R. 70 Federal Advisory Committee Act Amendments H.R. 493 Wall Street H.R. 585 Pre-Dispute Arbitration Agreement Prohibition H.R. 832 Consumer Financial Products Dispute Proceedings H.R. 1018 Director of the Bureau of Consumer Financial Protection H.R. 1031 Bureau of Consumer Financial Protection H.R. 1459 Regular Appropriations Process S. 365 Fund Transfer Funding Cap S. 370 Bureau of Consumer Financial Protection S. 387 Consumer Financial Protection Bureau Appropriations H.R. 2553 Bureau of Consumer Financial Protection H.R. 2750 Office of Financial Research Independent Funding S. 923 Financial Institutions Regulations Exemption

Client expense: $1,460,000 · Firm income: Not reported

Issues related to Dodd-Frank; H.R. 45 re Regulatory Relief H.R. 70 re Financial Reform H.R. 493 re Dodd-Frank Reform H.R. 585 re Financial Reform H.R. 832 re Consumer Financial Products H.R. 1018 re CFPB H.R. 1031 re CFPB H.R. 1459 re FSOC H.R. 1637 re CFPB S. 365 re CFPB S. 370 re Dodd-Frank Reform S. 387 re CFPB

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. General lobbying with regard to asbestos exposure and related health and environmental issues. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. General lobbying with regard to draft legislation relating to cosmetic regulation. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. General lobbying with regard to asbestos exposure and related health and environmental issues. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. Lobbying with specific regard to draft Personal Care Products Safety Act and legislation to regulate cosmetic products and ingredients. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending the Telephone Consumer Protection Act.